ArticleBMC infectious diseases2018
Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014.
Abstract read
In one paragraph
Article in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.
0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
60 citing papers in PubMed.
- Article
- Using interpretable machine learning models to predict the occurrence of severe influenza in hospitalized children: a retrospective cohort study.BMC medical informatics and decision making · 2026Article
- Epidemiology of SARS-CoV-2, Influenza, RSV, and Human Metapneumovirus Across the COVID-19 Era: An Eight-Year Tertiary-Center Study in Saudi Arabia.Pathogens (Basel, Switzerland) · 2026Observational
- Resurgence and clinical evolution of influenza A in Chinese children: shifting epidemiology and serological dynamics across pre-, intra-, and post-pandemic eras (2019-2023).BMC infectious diseases · 2026Article
- Prevalence, clinical features, and seasonal patterns of SARS-CoV-2, influenza, and HRSV in patients with a history of kidney transplantation in Iran.BMC infectious diseases · 2025Article
- N460S in PB2 and I163T in nucleoprotein synergistically enhance the viral replication and pathogenicity of influenza B virus.PLoS pathogens · 2025Article
- An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses.Nature communications · 2025Article
- Review
- Epidemiological patterns of influenza viruses among severe acute respiratory infection patients in Burkina Faso, 2016-2019: a surveillance study.The Pan African medical journal · 2025Article
- Article
- Influenza A virus continues to circulate among children in Linyi, northern China, after the relaxation of COVID-19 control measures.Scientific reports · 2024Article
- Cost-effectiveness of seasonal influenza vaccination in WHO-defined high-risk populations in Bangladesh.Journal of global health · 2024Article
- Forecasting of influenza activity and associated hospital admission burden and estimating the impact of COVID-19 pandemic on 2019/20 winter season in Hong Kong.PLoS computational biology · 2024Article
- The Hospital Burden of Flu in Italy: a retrospective study on administrative data from season 2014-2015 to 2018-2019.BMC infectious diseases · 2024Article
- The real-world safety of oseltamivir and baloxavir marboxil in children: a disproportionality analysis of the FDA adverse event reporting system.Frontiers in pharmacology · 2024Article
- Age-dependent influenza infection patterns and subtype circulation in Denmark, in seasons 2015/16 to 2021/22.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024Article
- Comparative Analysis of Symptomatology in Hospitalized Children with RSV, COVID-19, and Influenza Infections.Medical science monitor : international medical journal of experimental and clinical research · 2023Article
- Influenza hospitalisations in Spain between the last influenza and COVID-19 pandemic (2009-2019).Epidemiology and infection · 2023Article
- The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence.Human vaccines & immunotherapeutics · 2023Review
- Global variability of influenza activity and virus subtype circulation from 2011 to 2023.BMJ open respiratory research · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
64 authors.
Saverio CainiNetherlands Institute for Health Services Research (NIVEL), Otterstraat 118-124, 3513, CR, Utrecht, The Netherlands. s.caini@nivel.nl.
Peter SpreeuwenbergNetherlands Institute for Health Services Research (NIVEL), Otterstraat 118-124, 3513, CR, Utrecht, The Netherlands.
Gabriela F KusznierzInstituto Nacional de Enfermedades Respiratorias "Dr. Emilio Coni", Santa Fe, Argentina.
Juan Manuel RudiInstituto Nacional de Enfermedades Respiratorias "Dr. Emilio Coni", Santa Fe, Argentina.
Rhonda OwenVaccine Preventable Diseases Surveillance Section, Health Policy Protection branch, Office for Health Protection, Department of Health, Woden, Canberra, Australia.
Kate PenningtonVaccine Preventable Diseases Surveillance Section, Health Policy Protection branch, Office for Health Protection, Department of Health, Woden, Canberra, Australia.
Sonam WangchukPublic Health Laboratory, Department of Public Health, Ministry of Health, Thimphu, Bhutan.
Sonam GyeltshenPublic Health Laboratory, Department of Public Health, Ministry of Health, Thimphu, Bhutan.
Walquiria Aparecida Ferreira de AlmeidaMinistry of Health, Brasilia, DF, Brazil.
Cláudio Maierovitch Pessanha HenriquesMinistry of Health, Brasilia, DF, Brazil.
Richard NjouomVirology Department, Centre Pasteur of Cameroon, Yaoundé, Cameroon.
Marie-Astrid VernetVirology Department, Centre Pasteur of Cameroon, Yaoundé, Cameroon.
Rodrigo A FasceSección Virus Respiratorios, Instituto de Salud Pública de Chile, Santiago, Chile.
Winston AndradeSección Virus Respiratorios, Instituto de Salud Pública de Chile, Santiago, Chile.
Hongjie YuDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Luzhao FengDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Juan YangDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhibin PengDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Jenny LaraNational Influenza Center, Ministry of Health, San José, Costa Rica.
Alfredo BrunoInstituto Nacional de Investigacion en Salud Publica (INSPI), Centro de Referencia Nacional de Influenza y otros Virus Respiratorios, Guayaquil, Ecuador.
Doménica de MoraInstituto Nacional de Investigacion en Salud Publica (INSPI), Centro de Referencia Nacional de Influenza y otros Virus Respiratorios, Guayaquil, Ecuador.
Celina de LozanoNational Influenza Center, Ministry of Health, San Salvador, El Salvador.
Maria ZambonRespiratory Virus Unit, Public Health England, London, Colindale, UK.
Richard PebodyRespiratory Diseases Department, Public Health England, London, Colindale, UK.
Leticia CastilloNational Influenza Center, Ministry of Health, Guatemala City, Guatemala.
Alexey W ClaraUS Centers for Disease Control, Central American Region, Guatemala City, Guatemala.
Maria Luisa MatuteNational Influenza Center, Ministry of Health, Tegucigalpa, Honduras.
Herman KosasihUS Naval Medical Research Unit No.2, Jakarta, Indonesia.
NurhayatiUS Naval Medical Research Unit No.2, Jakarta, Indonesia.
Simona PuzelliNational Influenza Center, National Institute of Health, Rome, Italy.
Caterina RizzoNational Center for Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome, Italy.
Herve A KadjoDepartment of Epidemic Virus, Institut Pasteur, Abidjan, Côte d'Ivoire.
Coulibaly DaoudaService of Epidemiological Diseases Surveillance, National Institute of Public Hygiene, Abidjan, Côte d'Ivoire.
Lyazzat KiyanbekovaNational Center of Expertise, Committee of Consumer Right Protection, Astana, Kazakhstan.
Akerke OspanovaZonal Virology Laboratory, National Center of Expertise, Committee of Consumer Right Protection, Astana, Kazakhstan.
Joshua A MottCenters for Disease Control and Prevention - Kenya Country Office, Nairobi, Kenya.
Gideon O EmukuleCenters for Disease Control and Prevention - Kenya Country Office, Nairobi, Kenya.
Jean-Michel HeraudNational Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo, Madagascar.
Norosoa Harline RazanajatovoNational Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo, Madagascar.
Amal BarakatNational Influenza Center, Institut National d'Hygiène, Ministry of Health, Rabat, Morocco.
Fatima El FalakiNational Influenza Center, Institut National d'Hygiène, Ministry of Health, Rabat, Morocco.
Sue Q HuangInstitute of Environmental Science and Research, Wellington, New Zealand.
Liza LopezInstitute of Environmental Science and Research, Wellington, New Zealand.
Angel BalmasedaNational Influenza Center, Ministry of Health, Managua, Nicaragua.
Brechla MorenoNational Influenza Center, IC Gorgas, Panama City, Panama.
Ana Paula RodriguesDepartment of epidemiology, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Raquel GuiomarNational Influenza Reference Laboratory, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Li Wei AngEpidemiology and Disease Control Division, Ministry of Health, Singapore, Singapore.
Vernon Jian Ming LeeCommunicable Diseases Division, Ministry of Health, Singapore, Singapore.
Marietjie VenterGlobal Disease Detection, US-CDC, Pretoria, South Africa.
Cheryl CohenCentre for Respiratory Diseases and Meningitis (CRDM), National Institute for Communicable Diseases, Johannesburg, South Africa.
Selim BadurIstanbul University, Istanbul, Turkey.
Meral A CiblakIstanbul University, Istanbul, Turkey.
Alla MironenkoL.V.Gromashevsky Institute of Epidemiology and Infectious Diseases National Academy of Medical Science of Ukraine, Reiv, Ukraine.
Olha HolubkaL.V.Gromashevsky Institute of Epidemiology and Infectious Diseases National Academy of Medical Science of Ukraine, Reiv, Ukraine.
Joseph BreseeEpidemiology and Prevention Branch, Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lynnette BrammerEpidemiology and Prevention Branch, Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Phuong Vu Mai HoangNational Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Mai Thi Quynh LeNational Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Douglas FlemingIndependent scientist, Birmingham, UK.
Clotilde El-Guerche SéblainSanofi Pasteur, Lyon, France.
François SchellevisNetherlands Institute for Health Services Research (NIVEL), Otterstraat 118-124, 3513, CR, Utrecht, The Netherlands.
John PagetNetherlands Institute for Health Services Research (NIVEL), Otterstraat 118-124, 3513, CR, Utrecht, The Netherlands.
Global Influenza B Study group
Funding
Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09U01IP001048 · IP · NATIONAL HEALTH LABORATORY SERVICE · PI COHEN, CHERYL · 2016 to 2020
$19.9MNCIRD CDC HHS U01 IP001048
Abstract
backgroundInfluenza disease burden varies by age and this has important public health implications. We compared the proportional distribution of different influenza virus types within age strata using surveillance data from twenty-nine countries during 1999-2014 (N=358,796 influenza cases).
methodsFor each virus, we calculated a Relative Illness Ratio (defined as the ratio of the percentage of cases in an age group to the percentage of the country population in the same age group) for young children (0-4 years), older children (5-17 years), young adults (18-39 years), older adults (40-64 years), and the elderly (65+ years). We used random-effects meta-analysis models to obtain summary relative illness ratios (sRIRs), and conducted meta-regression and sub-group analyses to explore causes of between-estimates heterogeneity.
resultsThe influenza virus with highest sRIR was A(H1N1) for young children, B for older children, A(H1N1)pdm2009 for adults, and (A(H3N2) for the elderly. As expected, considering the diverse nature of the national surveillance datasets included in our analysis, between-estimates heterogeneity was high (I
conclusionsThese results highlight the importance of presenting burden of disease estimates by age group and virus (sub)type.
Indexed as
AdolescentAdultAgedAge FactorsChildChild, PreschoolDatabases, FactualFemaleGlobal HealthHumansInfantInfant, NewbornInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza, HumanMaleAge distributionH1N1 subtypeH3N2 subtypeInfluenzaInfluenza A virusInfluenza B virusMeta-analysis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.